Cellular and molecular effects of the antidepressant hyperforin on brain cells: Review of the literature;Effets cellulaires et moléculaires de l'hyperforine, un antidépresseur végétal: revue de la littérature

Encephale

Volumn 40, Issue 2, 2014, Pages 108-113

  Bouron, A ^a,b   Lorrain, E ^c  

^a CEA GRENOBLE   (France)

^b UNIV GRENOBLE ALPES   (France)

^c Institut Européen des Substances Végétales   (France)

Author keywords

Antidepressant; Brain; Calcium; Hyperforin; TRPC6 channels; Zinc

Indexed keywords

4 AMINOBUTYRIC ACID; BRAIN DERIVED NEUROTROPHIC FACTOR; CALCIUM; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; DOPAMINE; GLUTAMIC ACID; HYPERFORIN; HYPERICUM PERFORATUM EXTRACT; N METHYL DEXTRO ASPARTIC ACID; NORADRENALIN; SODIUM; TRANSIENT RECEPTOR POTENTIAL CHANNEL 1; TRANSIENT RECEPTOR POTENTIAL CHANNEL 3; TRANSIENT RECEPTOR POTENTIAL CHANNEL 4; TRANSIENT RECEPTOR POTENTIAL CHANNEL 5; TRANSIENT RECEPTOR POTENTIAL CHANNEL 6; TRANSIENT RECEPTOR POTENTIAL CHANNEL 7; ZINC; ANTIDEPRESSANT AGENT; HYPERICIN; PERYLENE; PHLOROGLUCINOL; TERPENE;

ANTIDEPRESSANT ACTIVITY; ARTICLE; BRAIN CELL; CELL LINE; CELL MEMBRANE; CELL TYPE; HUMAN; HYPERICUM PERFORATUM; IN VITRO STUDY; INTRACELLULAR SIGNALING; PROTEIN EXPRESSION; SYNAPTIC TRANSMISSION; UPREGULATION; ANALOGS AND DERIVATIVES; BRAIN; CHEMISTRY; DRUG EFFECTS; HYPERICUM; NERVE CELL; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANTIDEPRESSIVE AGENTS; BRAIN; HYPERICUM; NEURONS; PERYLENE; PHLOROGLUCINOL; TERPENES;

EID: 84899128222     PISSN: 00137006     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.encep.2013.03.004     Document Type: Article

References (32)

1. R.B. Wills, K. Bone, and M. Morgan Herbal products: active constituents, modes of action and quality control Nutr Res Rev 13 1 2000 47 77
2. C. Stevinson, and E. Ernst Safety of hypericum in patients with depression: a comparison with conventional antidepressants CNS Drugs 11 2 1999 125 132
3. E. Schrader Equivalence of St John's wort extract (Ze 117) and fluoxetin: a randomized controlled study in mild-moderate depression Int Clin Psychopharmacol 15 2000 61 68
4. A. Szegedi, R. Kohnen, and A. Dienel et al. Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's wort): randomised controlled double blind non-inferiority trial versus paroxetine Br Med J 330 2005 503
5. H. Woelk Comparison of St John's wort and imipramine for treating depression: randomised controlled trial Br Med J 321 7260 2000 536 539
6. A. Brattstrom Long-term effects of St. John's wort (Hypericum perforatum) treatment: a 1-year safety study in mild to moderate depression Phytomedicine 16 4 2009 277 283
7. S.S. Chatterjee, M. Noldner, and E. Koch et al. Antidepressant activity of hypericum perforatum and hyperforin: the neglected possibility Pharmacopsychiatry 31 Suppl. 1 1998 7 15
8. G. Laakmann, C. Schule, and T. Baghai et al. St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy Pharmacopsychiatry 31 Suppl. 1 1998 54 59
9. C.M. Schempp, K. Pelz, and A. Wittmer et al. Antibacterial activity of hyperforin from St John's wort, against multiresistant Staphylococcus aureus and Gram-positive bacteria Lancet 353 9170 1999 2129
10. V. Butterweck, and M. Schmidt St. John's wort: role of active compounds for its mechanism of action and efficacy Wien Med Wochenschr 157 13-14 2007 356 361
11. K. Leuner, V. Kazanski, and M. Muller et al. Hyperforin - a key constituent of St. John's wort specifically activates TRPC6 channels Faseb J 21 14 2007 4101 4111
12. J. Gibon, J.C. Deloulme, and T. Chevalier et al. The antidepressant hyperforin increases the phosphorylation of CREB and the expression of TrkB in a tissue-specific manner Int J Neuropsychopharmacol 16 2013 189 198
13. P. Tu, J. Gibon, and A. Bouron The TRPC6 channel activator hyperforin induces the release of zinc and calcium from mitochondria J Neurochem 112 2010 204 213
14. J. Gibon, P. Richaud, and A. Bouron Hyperforin changes the zinc-storage capacities of brain cells Neuropharmacology 61 2011 1321 1326
15. E.C. Cope, and C.W. Levenson Role of zinc in the development and treatment of mood disorders Curr Opin Clin Nutr Metab Care 13 6 2010 685 689
16. B. Froestl, B. Steiner, and W.E. Muller Enhancement of proteolytic processing of the beta-amyloid precursor protein by hyperforin Biochem Pharmacol 66 11 2003 2177 2184
17. N. Roz, and M. Rehavi Hyperforin depletes synaptic vesicles content and induces compartmental redistribution of nerve ending monoamines Life Sci 75 23 2004 2841 2850
18. G.P. Eckert, J.H. Keller, and C. Jourdan et al. Hyperforin modifies neuronal membrane properties in vivo Neurosci Lett 367 2 2004 139 143
19. M. Hoffmann, J.J. Lopez, and C. Pergola et al. Hyperforin induces Ca(2+)-independent arachidonic acid release in human platelets by facilitating cytosolic phospholipase A(2) activation through select phospholipid interactions Biochim Biophys Acta 1801 4 2010 462 472
20. O. Suzuki, Y. Katsumata, and M. Oya et al. Inhibition of monoamine oxidase by hypericin Planta Med 50 3 1984 272 274
21. S.S. Chatterjee, S.K. Bhattacharya, and M. Wonnemann et al. Hyperforin as a possible antidepressant component of hypericum extracts Life Sci 63 6 1998 499 510
22. K. Simbrey, H. Winterhoff, and V. Butterweck Extracts of St. John's wort and various constituents affect beta-adrenergic binding in rat frontal cortex Life Sci 74 8 2004 1027 1038
23. M. Maes Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression Prog Neuropsychopharmacol Biol Psychiatry 35 3 2011 664 675
24. D. Albert, I. Zundorf, and T. Dingermann et al. Hyperforin is a dual inhibitor of cyclooxygenase-1 and 5-lipoxygenase Biochem Pharmacol 64 12 2002 1767 1775
25. M. Gobbi, F.D. Valle, and C. Ciapparelli et al. Hypericum perforatum L. extract does not inhibit 5-HT transporter in rat brain cortex Naunyn Schmiedebergs Arch Pharmacol 360 3 1999 262 269
26. Y. Li, B.W. Luikart, and S. Birnbaum et al. TrkB regulates hippocampal neurogenesis and governs sensitivity to antidepressive treatment Neuron 59 3 2008 399 412
27. N.A. DeCarolis, and A.J. Eisch Hippocampal neurogenesis as a target for the treatment of mental illness: a critical evaluation Neuropharmacology 58 6 2010 884 893
28. F. Merhi, R. Tang, and M. Piedfer et al. Hyperforin inhibits AKT1 kinase activity and promotes caspase-mediated apoptosis involving bad and noxa activation in human myeloid tumor cells PLoS One 6 10 2011 e25963
29. V. Klusa, S. Germane, and M. Noldner et al. Hypericum extract and hyperforin: memory-enhancing properties in rodents Pharmacopsychiatry 34 Suppl. 1 2001 S61 S69
30. T.N. Griffith, L. Varela-Nallar, and M.C. Dinamarca et al. Neurobiological effects of Hyperforin and its potential in Alzheimer's disease therapy Curr Med Chem 17 5 2010 391 406
31. A. Biber, H. Fischer, and A. Romer et al. Oral bioavailability of hyperforin from hypericum extracts in rats and human volunteers Pharmacopsychiatry 31 Suppl. 1 1998 36 43
32. L. Cervo, M. Rozio, and C.B. Ekalle-Soppo et al. Role of hyperforin in the antidepressant-like activity of Hypericum perforatum extracts Psychopharmacology (Berl) 164 4 2002 423 428